EVOFEM BIOSCIENCES INC (EVFM)
US30048L2034 - Common Stock
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.76M | 7.73M | 48.90M | 15.60M | 1.30M | |||
| Marketable Securities | N/A | N/A | 0.00 | 8.20M | N/A | |||
| Receivables | 4.42M | 6.45M | 1.30M | 700.00K | 400.00K | |||
| Inventories | 5.39M | 7.67M | 7.20M | N/A | N/A | |||
| Other Current Assets | 8.80M | 8.29M | 40.40M | 1.90M | 700.00K | |||
| Total Current Assets | 21.36M | 30.14M | 97.70M | 26.40M | 2.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.51M | 11.17M | 11.20M | 600.00K | 600.00K | |||
| Other Non-Current Assets | 2.71M | 1.20M | 1.00M | 1.10M | 400.00K | |||
| Total Non-Current Assets | 13.21M | 12.37M | 12.30M | 1.90M | 1.50M | |||
| TOTAL ASSETS | 34.57M | 42.51M | 110.00M | 28.30M | 4.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 267.00K | 0.00 | 52.40M | 0.00 | 4.00M | |||
| Current Portion Of LT Debt. | 113.82M | 108.93M | N/A | N/A | N/A | |||
| Accrued Expenses | 17.09M | 15.36M | 13.30M | 6.70M | 14.40M | |||
| Accounts Payable | 14.04M | 10.32M | 10.60M | 6.00M | 8.90M | |||
| Other Current Liabilities | 9.26M | 3.07M | 1.00M | N/A | 0.00 | |||
| Total Current Liabilities | 154.47M | 137.66M | 77.30M | 12.70M | 27.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 25.20M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.06M | 4.42M | 6.10M | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 4.06M | 4.42M | 31.30M | 0.00 | 100.00K | |||
| TOTAL LIABILITIES | 158.53M | 142.09M | 108.60M | 12.70M | 27.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -892.57M | -860.68M | -655.50M | -513.20M | -433.10M | |||
| Additional Paid In Capital | 759.20M | 751.26M | 656.80M | 528.80M | 409.80M | |||
| Common Shares | 4.14M | 4.76M | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 5.27M | 5.09M | N/A | N/A | N/A | |||
| Shares Outstanding | 12.32M | 10.83M | 81.40M | 48.10M | 25.90M | |||
| Tangible Book Value per Share | -10.40 | -9.63 | 0.02 | 0.32 | -0.90 | |||
| Total Shareholders' Equity | -123.96M | -99.58M | 1.30M | 15.60M | -23.40M | |||
| TOTAL LIABILITIES AND EQUITY | 34.57M | 42.51M | 110.00M | 28.30M | 4.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 59.69 | N/A | N/A | |||
| Current Ratio | 0.14 | 0.22 | 1.26 | 2.08 | 0.09 | |||
| Return On Assets (ROA) | -552.28% | -482.67% | -129.37% | -282.79% | -3142.75% | |||
| Return On Equity (ROE) | N/A | N/A | -10946.92% | -513.01% | N/A | |||
All data in USD